(HUN) Huntsman - Ratings and Ratios
Polyurethanes, Epoxy, Amines, Surfactants, Pigments
HUN EPS (Earnings per Share)
HUN Revenue
Description: HUN Huntsman
Huntsman Corporation (NYSE:HUN) is a US-based company operating in the Diversified Chemicals sub-industry. The companys stock performance is being analyzed, particularly in relation to its quarterly tax provision.
To understand the companys financial health, key metrics such as Market Cap ($1.65B) and P/E Forward (17.48) are crucial. The negative RoE (-10.87%) indicates that the company has been struggling with profitability. This could be due to various factors, including high operating costs, intense competition, or economic downturns affecting demand for its products.
The Diversified Chemicals industry is subject to fluctuations in raw material costs, regulatory changes, and global demand. Huntsmans performance is likely influenced by its product portfolio, production capacity, and geographic presence. Key economic drivers for the company include global GDP growth, industrial production indices, and trends in the construction, automotive, and consumer goods sectors, which are significant consumers of chemical products.
To assess the companys stock, investors should monitor KPIs such as revenue growth, EBITDA margins, and cash flow generation. A thorough analysis of Huntsmans quarterly tax provision would involve examining the effective tax rate, tax credits, and any one-time tax adjustments. This information can provide insights into the companys tax strategy and potential future tax liabilities.
The stocks technical indicators, such as its beta (0.713) and ATR (0.46), suggest relatively lower volatility compared to the broader market. However, the stock price has been under pressure, with a 52-week low of $9.06 and a high of $23.59, indicating significant price fluctuations. Investors should consider these factors when evaluating the stocks potential for future growth or decline.
HUN Stock Overview
| Market Cap in USD | 1,937m |
| Sub-Industry | Diversified Chemicals |
| IPO / Inception | 2005-02-11 |
HUN Stock Ratings
| Growth Rating | -81.7% |
| Fundamental | 29.7% |
| Dividend Rating | 82.8% |
| Return 12m vs S&P 500 | -55.0% |
| Analyst Rating | 3.13 of 5 |
HUN Dividends
| Dividend Yield 12m | 7.58% |
| Yield on Cost 5y | 5.31% |
| Annual Growth 5y | 9.00% |
| Payout Consistency | 97.1% |
| Payout Ratio | 180.0% |
HUN Growth Ratios
| Growth Correlation 3m | -4.9% |
| Growth Correlation 12m | -95.8% |
| Growth Correlation 5y | -54.2% |
| CAGR 5y | -20.72% |
| CAGR/Max DD 3y | -0.30 |
| CAGR/Mean DD 3y | -0.85 |
| Sharpe Ratio 12m | -2.08 |
| Alpha | 0.00 |
| Beta | 0.977 |
| Volatility | 49.37% |
| Current Volume | 6098.4k |
| Average Volume 20d | 4228.2k |
| Stop Loss | 10.3 (-5.5%) |
| Signal | 1.45 |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-322.0m TTM) > 0 and > 6% of Revenue (6% = 351.6m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA 0.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.33% (prev 8.82%; Δ 2.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 299.0m > Net Income -322.0m (YES >=105%, WARN >=100%) |
| Net Debt (1.64b) to EBITDA (207.0m) ratio: 7.90 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.43 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (172.6m) change vs 12m ago -0.12% (target <= -2.0% for YES) |
| Gross Margin 13.74% (prev 13.89%; Δ -0.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 81.03% (prev 81.36%; Δ -0.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.99 (EBITDA TTM 207.0m / Interest Expense TTM 80.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.68
| (A) 0.09 = (Total Current Assets 2.21b - Total Current Liabilities 1.54b) / Total Assets 7.15b |
| (B) 0.28 = Retained Earnings (Balance) 1.99b / Total Assets 7.15b |
| (C) -0.01 = EBIT TTM -79.0m / Avg Total Assets 7.23b |
| (D) 0.22 = Book Value of Equity 900.0m / Total Liabilities 4.09b |
| Total Rating: 1.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 29.69
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield 3.78% = 1.89 |
| 3. FCF Margin 2.30% = 0.58 |
| 4. Debt/Equity 0.72 = 2.25 |
| 5. Debt/Ebitda 9.83 = -2.50 |
| 6. ROIC - WACC (= -6.72)% = -8.40 |
| 7. RoE -10.87% = -1.81 |
| 8. Rev. Trend -73.12% = -5.48 |
| 9. EPS Trend -76.50% = -3.83 |
What is the price of HUN shares?
Over the past week, the price has changed by -0.66%, over one month by +11.00%, over three months by +3.01% and over the past year by -46.61%.
Is Huntsman a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HUN is around 9.29 USD . This means that HUN is currently overvalued and has a potential downside of -14.77%.
Is HUN a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 12
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the HUN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 11.2 | 2.3% |
| Analysts Target Price | 11.2 | 2.3% |
| ValueRay Target Price | 10 | -7.9% |
Last update: 2025-09-13 04:36
HUN Fundamental Data Overview
CCE Cash And Equivalents = 399.0m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 185.1852
P/S = 0.3306
P/B = 0.6851
P/EG = 1.79
Beta = 0.66
Revenue TTM = 5.86b USD
EBIT TTM = -79.0m USD
EBITDA TTM = 207.0m USD
Long Term Debt = 1.66b USD (from longTermDebt, last quarter)
Short Term Debt = 372.0m USD (from shortTermDebt, last quarter)
Debt = 2.04b USD (Calculated: Short Term 372.0m + Long Term 1.66b)
Net Debt = 1.64b USD (from netDebt column, last quarter)
Enterprise Value = 3.57b USD (1.94b + Debt 2.04b - CCE 399.0m)
Interest Coverage Ratio = -0.99 (Ebit TTM -79.0m / Interest Expense TTM 80.0m)
FCF Yield = 3.78% (FCF TTM 135.0m / Enterprise Value 3.57b)
FCF Margin = 2.30% (FCF TTM 135.0m / Revenue TTM 5.86b)
Net Margin = -5.49% (Net Income TTM -322.0m / Revenue TTM 5.86b)
Gross Margin = 13.74% ((Revenue TTM 5.86b - Cost of Revenue TTM 5.05b) / Revenue TTM)
Tobins Q-Ratio = 3.97 (Enterprise Value 3.57b / Book Value Of Equity 900.0m)
Interest Expense / Debt = 1.03% (Interest Expense 21.0m / Debt 2.04b)
Taxrate = 21.0% (US default)
NOPAT = -79.0m (EBIT -79.0m, no tax applied on loss)
Current Ratio = 1.43 (Total Current Assets 2.21b / Total Current Liabilities 1.54b)
Debt / Equity = 0.72 (Debt 2.04b / last Quarter total Stockholder Equity 2.83b)
Debt / EBITDA = 9.83 (Net Debt 1.64b / EBITDA 207.0m)
Debt / FCF = 15.07 (Debt 2.04b / FCF TTM 135.0m)
Total Stockholder Equity = 2.96b (last 4 quarters mean)
RoA = -4.51% (Net Income -322.0m, Total Assets 7.15b )
RoE = -10.87% (Net Income TTM -322.0m / Total Stockholder Equity 2.96b)
RoCE = -1.71% (Ebit -79.0m / (Equity 2.96b + L.T.Debt 1.66b))
RoIC = -1.62% (NOPAT -79.0m / Invested Capital 4.88b)
WACC = 5.10% (E(1.94b)/V(3.97b) * Re(9.61%)) + (D(2.04b)/V(3.97b) * Rd(1.03%) * (1-Tc(0.21)))
Shares Correlation 3-Years: -61.55 | Cagr: -1.29%
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 63.72% ; FCFE base≈114.2m ; Y1≈75.0m ; Y5≈34.3m
Fair Price DCF = 3.05 (DCF Value 530.0m / Shares Outstanding 173.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -76.50 | EPS CAGR: -61.77% | SUE: -0.84 | # QB: 0
Revenue Correlation: -73.12 | Revenue CAGR: -11.04%
Additional Sources for HUN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle